Testing Two Different Intensities of an Intervention to Enhance REsilience and to Reduce SupportIve Care Needs in Cancer Patients
NCT ID: NCT03045003
Last Updated: 2017-02-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
86 participants
INTERVENTIONAL
2014-01-01
2015-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
"Resilient Caregivers" - A Resilience-based Intervention for Distressed Partner Cancer Caregivers
NCT04610034
Promoting Resilience in Early Survivorship Among Adolescents and Young Adults With Cancer
NCT06038318
Testing of the Cancer Thriving and Surviving Breast Cancer Program
NCT03651921
Remote Psychosocial Intervention for Brain Tumour Survivors
NCT02439931
A Stress Management and Resiliency Program for Adolescent and Young Adult Survivors
NCT03768336
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Intervention B (tested in arm B) includes same intervention as arm A supplemented by 5 structured nurse led consultations, two face to face (F2F), three by phone (PC) provided by clinical nurse specialists and based on a consultation manual.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Arm A: Low Intensity
RESIL Intervention provided by nurses and oncologists of the outpatient oncology unit.
RESIL Intervention
Interventions tested in this study are the following: i) educational sessions with oncologists and nurses, ii) direct, electronic feed-back of resilience and needs screening in a monitoring sheet including intervention propositions and iii) consultation provided by a clinical nurse specialist to patients (in intervention B only) Interventions have been developed based on previous studies on the efficacy of screening of patient reported outcomes and direct feed-back to health care professionals and on previous studies on interventions to enhance resilience in nursing or psycho-oncology with proven efficacy. Interventions provided in the monitoring sheet have been validated by experienced Swiss oncology nurses, oncologists and psycho-oncologists.
Arm B: High Intensity
RESIL Intervention provided by nurses and oncologists of the outpatient oncology unit plus 5 nurse-led consultations (3 face-to-face and 2 telephone consultations)
RESIL Intervention
Interventions tested in this study are the following: i) educational sessions with oncologists and nurses, ii) direct, electronic feed-back of resilience and needs screening in a monitoring sheet including intervention propositions and iii) consultation provided by a clinical nurse specialist to patients (in intervention B only) Interventions have been developed based on previous studies on the efficacy of screening of patient reported outcomes and direct feed-back to health care professionals and on previous studies on interventions to enhance resilience in nursing or psycho-oncology with proven efficacy. Interventions provided in the monitoring sheet have been validated by experienced Swiss oncology nurses, oncologists and psycho-oncologists.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
RESIL Intervention
Interventions tested in this study are the following: i) educational sessions with oncologists and nurses, ii) direct, electronic feed-back of resilience and needs screening in a monitoring sheet including intervention propositions and iii) consultation provided by a clinical nurse specialist to patients (in intervention B only) Interventions have been developed based on previous studies on the efficacy of screening of patient reported outcomes and direct feed-back to health care professionals and on previous studies on interventions to enhance resilience in nursing or psycho-oncology with proven efficacy. Interventions provided in the monitoring sheet have been validated by experienced Swiss oncology nurses, oncologists and psycho-oncologists.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* attending the clinic for the first chemotherapy administration
* newly diagnosed (between 4-15 weeks after diagnosis) with a new carcinoma / lymphoma
* sufficiently literate in French or German to complete questionnaires.
Exclusion Criteria
* being treated in in-patient or palliative care units
* diagnosed with all other cancers
* in need of complex chemotherapy
* being judged by the oncologist as not being emotionally or physically capable to participate in the trial will be excluded.
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
ETOP IBCSG Partners Foundation
NETWORK
Hôpital Fribourgeois
OTHER
University of Applied Sciences of Western Switzerland
OTHER
Manuela Eicher
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Manuela Eicher
Professeure Associée
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Manuela Eicher, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Lausanne
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RESIL Trial
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.